MABURA 40MG/0.8ML INJECTION

Mabura 40mg/0.8ml Injection is a targeted biologic therapy used in the treatment of moderate to severe rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, and certain autoimmune conditions. It contains Tocilizumab, an interleukin‑6 (IL‑6) receptor antagonist that helps calm inflammatory responses in the body. This injectable biologic supports improved joint function and reduced pain when prescribed by a healthcare professional.

Mabura 40 mg/0.8 ml Injection works by blocking IL‑6, a key signaling protein involved in chronic inflammation.  Interrupting this pathway helps reduce swelling, stiffness, and joint damage associated with autoimmune diseases.  Regular treatment under medical supervision can significantly improve mobility and quality of life for eligible patients.  Monitoring of blood counts and liver function during therapy ensures optimal safety.

Mabura 40 mg/0.8 ml Injection ensures consistent potency, safety, and efficacy.  It is widely supplied to hospitals, specialty clinics, and global pharmaceutical buyers looking for advanced biologic solutions in autoimmune care.

Product Features

• Contains Tocilizumab 40mg per 0.8 ml
• Interleukin‑6 (IL‑6) receptor antagonist
• Used for rheumatoid arthritis & autoimmune diseases
• Supports the reduction of inflammation and joint damage
• High‑quality sterile injectable biologic formulation

How It Helps

• Reduces chronic inflammation
• Improves joint mobility and comfort
• Helps slow progression of autoimmune disease
• Supports improved quality of life